About Avantor

Avantor, Inc. (Avantor) operates as a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company’s business model is grounded in supporting its customers from discovery to delivery and Avantor is embedded in virtually every stage of the most important research, scale-up and manufacturing activities in the industries the company serves. The company’s comprehensive offering provides scientists all they need to conduct their research: materials & consumables, equipment & instrumentation and services & specialty procurement. The company’s customer-centric innovation model enables the company to provide solutions for some of the most demanding applications, and the company leverages its comprehensive offering and access to early-stage research to identify and develop content and solutions that ultimately become specified into the company’s customers’ approved production platforms. The company’s broad portfolio of products and services, fully integrated business model and global supply chain enable the company to support its customers’ journey every step of the way. The company has a number of distinctive capabilities that set the company apart from other companies in its space. For example, the company’s global footprint offers extraordinary customer access, enabling the company to serve more than 300,000 customer locations in more than 180 countries around the world. In June 2021, the company acquired Ritter, a manufacturer of high-quality robotic and liquid handling consumables used in a variety of molecular screening and diagnostic applications. In November 2021, the company acquired the Masterflex bioprocessing business of Antylia Scientific. Masterflex is a leading global manufacturer of peristaltic pumps and aseptic single-use fluid transfer technologies. Business segments The company has reported financial results in three geographic segments based on customer location: the Americas, Europe and AMEA. Within each of the company’s geographic segments, the company sells materials & consumables, equipment & instrumentation and services & specialty procurement to customers in the biopharma, healthcare, education & government and advanced technologies & applied materials industries. The company works with customers across these sophisticated, science-driven industries that require innovation and adherence to the most demanding technical and regulatory requirements. On December 7, 2023, the company disclosed that it will transition from three geographic segments to two complementary business segments focused on customer needs: Laboratory Solutions and Bioscience Production, effective January 1, 2024. Products and Services The company’s portfolio includes a comprehensive range of products and services that allows the company to create customized and integrated solutions for the company’s customers. These products and services enable the company’s customers to achieve precise analytical results in their research, diagnostic, and quality assurance and quality control activities. The company’s products and services are as follows: Materials & consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips. Some of these are proprietary products that the company makes while others are produced by third parties; Equipment & instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets and critical environment supplies; and Services & specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services. In aggregate, the company provides millions of SKUs, including high value specialty products developed to exacting purity and performance specifications. The company’s e-commerce platform, Avantor ScienceCentral, makes it easy for customers to do business with the company and enables digital marketing efforts that position the company to capture new demand. All of the company’s capabilities are underpinned by its Avantor Business System, which drives execution and continuous improvement. The company manufactures products that meet or exceed the demanding requirements of its customers across a number of highly-regulated industries. The company’s high-purity and ultra-high purity products, such as its J.T.Baker brand chemicals, are trusted by life sciences and electronic materials customers around the world and can be manufactured at purity levels as stringent as one part-per-trillion. Similarly, the company’s NuSil brand of high-purity, customized silicones has been trusted by leading medical device manufacturers and aerospace companies. The company’s services organization of over 2,500 colleagues work side-by-side with its customers to support their workflows. The company’s traditional service offerings focus on the needs of laboratory scientists and include procurement, logistics, chemical and equipment tracking and glassware autoclaving. In addition, the company offers more complex and value-added scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository services and compound management. Sales Channels The company reaches its customers throughout the Americas, Europe and AMEA via a well-trained global sales force, comprehensive websites and targeted catalogs. The company’s sales force is consisted of approximately 3,700 sales and sales support professionals, including over 200 sales specialists selected for their in-depth industry and product knowledge. The company’s sales professionals include native speakers for each of the countries in which the company operates, allowing the company to have high impact interactions with its customers across the globe. The company’s e-commerce platform, Avantor ScienceCentral, plays a vital role in how the company conducts business with its customers. In 2023, approximately 75% of the company’s transactions came from its digital channels. The company’s websites utilize search analytics and feature personalized search tools, customer specific web solutions and enhanced data that optimize its customers’ online purchasing experience with rich content and AI-based recommendations and better integrate the company’s customers’ processes with the company’s own. The company’s websites are designed to integrate acquisitions, drive geographical expansion and serve segmented market needs with ease. In addition, the company has introduced digital services and solutions that streamline lab procurement and operations, and has become embedded into many customers’ laboratories, such as Avantor’s Inventory Manager. Intellectual Property The company has applied in the United States and certain foreign countries for registration of number of trademarks, service marks and patents, some of which have been registered and issued. The company also holds common law rights in various trademarks and service marks. Other than the company’s Avantor, VWR, J.T.Baker, NuSil and Masterflex trademarks, the company does not consider any particular patent, trademark, license, franchise or concession to be material to the company’s overall business. Government Contracts The company conducts business with various government agencies and government contractors. Government Regulation The company’s facilities that engage in the manufacturing, packaging, distribution and other biopharmaceutical and biomaterials production, as well as many of the company’s products themselves, are subject to extensive ongoing regulation by the U.S. governmental authorities, the EMA and other global regulatory authorities. Certain of the company’s subsidiaries are required to register with these agencies, or to apply for permits and/or licenses with, and must comply with the operating, cGMP, quality and security standards of applicable domestic and foreign regulators, including the FDA, the DEA, the Bureau of Alcohol, Tobacco, Firearms and Explosives, DHHS, the equivalent agencies of European Union (EU) member states, and comparable foreign, state and local agencies, as well as various accrediting bodies, each depending upon the type of operation and the locations of storage or sale of the products manufactured or services provided by those subsidiaries in the event of noncompliance. In order to maintain certain certifications of quality and safety standards for the company’s manufacturing facilities and operations, the company must comply with numerous regulatory systems, standards, guidance and other requirements, as appropriate, including but not limited to, ICH Q7, the guidelines of the International Pharmaceutical Excipients Council, European in vitro diagnostic medical device directives, the U.S. Pharmacopeia / National Formulary, as well as the European, British, Japanese, Indian and Chinese Pharmacopeia, the Food Chemicals Codex and controlled substances regulations. In addition, the company’s operations, and some of the products the company offers, are subject to a number of complex and stringent laws and regulations governing the production, handling, transportation and distribution of chemicals, drugs and other similar products. The company is subject to various federal, state, local, foreign and transnational laws, regulations and recommendations, both in the U.S. and abroad, relating to safe working conditions, good laboratory and distribution practices, and the safe and proper use, transportation and disposal of hazardous or potentially hazardous substances. In addition, the U.S. and international import and export laws and regulations, including those enforced by the U.S. Departments of Commerce, State and Treasury, OFAC and BIS, require the company to abide by certain standards relating to the cross-border transit of finished goods, raw materials and supplies and the handling of related information. The company’s logistics activities must comply with the rules and regulations of the U.S. Department of Transportation, Department of Homeland Security, Department of Commerce, Department of Defense, and the Federal Aviation Administration and similar foreign agencies. The company is also subject to various other laws and regulations concerning the conduct of its foreign operations, including the FCPA and other anti-bribery laws, as well as laws pertaining to the accuracy of the company’s internal books and records. In addition to the regulations described above, as part of the company’s aerospace and military offerings, the company is registered with the DDTC as a manufacturer and exporter of goods controlled by ITAR, and the company is subject to strict export control and prior approval requirements related to these goods. In connection with the company’s NuSil brand products, the company has one ITAR site registration and one ITAR product registration, and the company maintains control systems which enable ITAR compliance. The company is also subject to various federal, state and international laws and regulations related to privacy and data protection, including the EU’s General Data Protection Regulation (‘GDPR’), as well as the California Consumer Privacy Act of 2018 (‘CCPA’), which became effective on January 1, 2020 (as amended by the California Privacy Rights Act, which took effect on January 1, 2023, the ‘CPRA’). The interpretation and application of data privacy, cross-border data transfers and data protection laws and regulations are often uncertain and are evolving in the U.S. and internationally, such as in the EU, China and other jurisdictions. Environmental Matters The company is subject to various laws and governmental regulations concerning environmental, safety and health matters, including employee safety and health, in the U.S. and other countries. The U.S. federal environmental legislation that affects the company includes the Toxic Substances Control Act, the Resource Conservation and Recovery Act, the Clean Air Act, the Clean Water Act, the Safe Drinking Water Act, and CERCLA. These laws and regulations govern, among other things, air emissions, wastewater discharges, the use, handling and disposal of hazardous substances and wastes, soil and groundwater contamination and the general health and safety of the company’s associates and the communities in which the company operates. The company is also subject to regulation by OSHA concerning employee safety and health matters. History Avantor, Inc. was founded in 1904. The company was incorporated in Delaware in 2017.

Country
Industry:
Laboratory Analytical Instruments
Founded:
1904
IPO Date:
05/17/2019
ISIN Number:
I_US05352A1007
Address:
Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road, Radnor, Pennsylvania, 19087, United States
Phone Number
610 386 1700

Key Executives

CEO:
Stubblefield, Michael
CFO
Jones, R.
COO:
Data Unavailable